The overexpression and activation of MMP-9 by ROS and NF-kB may act as molecular mechanisms to explain the links between chronic intermittent hypoxia, inflammation, and endothelial dysfunction, all of which can lead to cardiovascular disease in patients with OSA [5]. Here, MMP9 is linked to endothelial dysfunction.